News

Climate change puts Lyme disease in focus for France's Valneva after COVID blow - Reuters

Reuters · last updated

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva (VLS.PA) is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.

View full article

here today, more tomorrow

We’ve launched briefing.center with a focus on the press and media.

And we’ve added Citizen Cartwright, a daily quick-read news summary by veteran Washington journalist Linda Cartwright. We’ve also created a new voting rights knowledge center for Citizen Cartwright subscribers. (You can sign up for a dedicated morning email at citizencartwright.com.)

You can sign up here for full access to press and media and Citizen Cartwright on briefing.center.

You can use briefing.center as the center of your information management, or just one of your tools. We’re happy to discuss your information needs.

Sign up